Spyre Therapeutics, Inc. short interest in 2019

In 2019, Spyre Therapeutics, Inc.'s disclosed short interest ran from 1.28% of shares outstanding on 15 Oct 2019 to 0.70% on 31 Dec 2019, a change of -0.58 percentage points. The year's high was 1.28% on 15 Oct 2019 and its low 0.68% on 13 Dec 2019, averaging 0.91% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.84 days on 15 Oct 2019. Full history: Spyre Therapeutics, Inc..

Cite this page

Plain

Short position data for Spyre Therapeutics, Inc. short interest in 2019: FINRA, compiled by howshorted.com, settlement date 31 Dec 2019. https://howshorted.com/us/company/syre/2019/

Wikipedia

<ref>{{cite web |title=Spyre Therapeutics, Inc. short interest in 2019 short position data |url=https://howshorted.com/us/company/syre/2019/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2019-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-spyre-therapeutics-inc-short-interest-in-2019-12-31,
  title        = {Spyre Therapeutics, Inc. short interest in 2019 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/syre/2019/}},
  note         = {Data: FINRA, settlement date 31 Dec 2019; accessed 2026-10-13},
  year         = {2019}
}

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2019 in figures

Start of year: 1.28% (15 Oct 2019)
End of year: 0.70% (31 Dec 2019)
Change: -0.58 pp
High: 1.28% (15 Oct 2019)
Low: 0.68% (13 Dec 2019)
Average: 0.91%
Highest days to cover: 9.84 (15 Oct 2019)
SEC filings marked: 9

Every report in 2019

Spyre Therapeutics, Inc. short interest in 2019
Settlement	Short interest	Days to cover	Filings since previous
15 Oct 2019	1.28%	9.84	results (8-K), 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K)
31 Oct 2019	1.01%	8.58
15 Nov 2019	0.91%	7.82	10-Q filed, results (8-K)
29 Nov 2019	0.87%	3.60
13 Dec 2019	0.68%	3.09
31 Dec 2019	0.70%	2.90

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.